This content has not yet been reviewed and may contain errors.

allergy & immunology

1 min read Updated 2026-07-09
Contents

allergy & immunology

topic map

anaphylaxis & acute allergic reactions

  • anaphylaxis — WAO/NIAID diagnostic criteria, epinephrine dosing (IM & IV), biphasic reaction risk, differential diagnosis, disposition

urticaria & angioedema

  • urticaria and angioedema — histaminergic vs bradykinin-mediated, CSU management, antihistamine up-dosing, approach to angioedema
  • hereditary angioedema — bradykinin-mediated angioedema, HAE classification and diagnosis (C4/C1-INH), acute treatment (Berinert dosing), short-term and long-term prophylaxis, ACE inhibitor angioedema

drug allergy

  • drug allergy and cross-reactivity — immediate vs delayed reactions, beta-lactam cross-reactivity (side chain–based), PEN-FAST de-labelling, drug challenge protocols, TMP/SMX allergy, ASA/NSAID hypersensitivity, radiocontrast media (CAR/CSACI guidance), desensitisation indications
  • drug rashes — morbilliform drug eruption, DRESS (RegiSCAR), SJS/TEN (BSA classification), high-risk drugs, management by severity

immunodeficiency

  • approach to immunodeficiency — secondary vs primary, pattern recognition by organism/immune defect, initial workup (Ig levels, vaccine responses, HIV), when to refer, practical tips (pre-rituximab baseline, CD4 thresholds)

mastocytosis & mast cell disease

  • mastocytosis — KIT D816V, WHO diagnostic criteria (major + minor), cutaneous vs systemic classification, B/C-findings, tryptase interpretation, stepwise mediator management, avapritinib for advanced SM, trigger avoidance

eosinophilia

  • approach to eosinophilia — differential (NAACP: neoplasm, allergy, autoimmune, infection, parasites), clonal vs reactive workup, HES subtypes, end-organ damage assessment, stepwise management